Dicerna Pharmaceuticals Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

9/30/2021

Quarter

2021 Q3

Filed

11/15/2021

Shares

330,528

Value ($000)

6,663

Weight

0.0%

2019 Q4 - 2021 Q3 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q3	11/15/2021	6,663	0.0%	330,528	9/30/2021
2021 Q2	8/16/2021	12,716	0.0%	340,731	6/30/2021
2021 Q1	5/14/2021	8,759	0.0%	342,540	3/31/2021
2020 Q4	3/1/2021	7,402	0.0%	335,982	12/31/2020
2020 Q3	11/13/2020	6,368	0.0%	353,958	9/30/2020
2020 Q2	8/14/2020	8,919	0.0%	351,136	6/30/2020
2020 Q1	5/15/2020	6,019	0.0%	327,642	3/31/2020
2019 Q4	2/14/2020	1,284	0.0%	58,283	12/31/2019